IRIS
CORSICO, ANGELO GUIDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.690
AS - Asia 6.966
EU - Europa 5.466
SA - Sud America 1.150
Continente sconosciuto - Info sul continente non disponibili 292
AF - Africa 279
OC - Oceania 14
Totale 25.857
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.202
CN - Cina 2.898
SG - Singapore 1.713
IT - Italia 1.054
IE - Irlanda 956
BR - Brasile 843
HK - Hong Kong 752
VN - Vietnam 739
RU - Federazione Russa 611
DE - Germania 606
UA - Ucraina 509
FI - Finlandia 475
FR - Francia 406
GB - Regno Unito 304
SE - Svezia 205
CA - Canada 203
IN - India 185
BD - Bangladesh 175
ZA - Sudafrica 155
AR - Argentina 103
MX - Messico 77
IQ - Iraq 67
JP - Giappone 61
PL - Polonia 61
NL - Olanda 57
EC - Ecuador 54
CO - Colombia 51
ID - Indonesia 39
TR - Turchia 38
IL - Israele 37
ES - Italia 36
AT - Austria 35
CR - Costa Rica 35
SA - Arabia Saudita 35
BE - Belgio 34
PH - Filippine 34
PK - Pakistan 33
VE - Venezuela 29
CL - Cile 25
HN - Honduras 25
SV - El Salvador 25
MA - Marocco 24
NI - Nicaragua 23
TT - Trinidad e Tobago 22
JM - Giamaica 21
CW - ???statistics.table.value.countryCode.CW??? 20
CZ - Repubblica Ceca 20
UZ - Uzbekistan 20
TN - Tunisia 18
GT - Guatemala 17
LT - Lituania 17
PY - Paraguay 17
JO - Giordania 16
KE - Kenya 13
SC - Seychelles 13
AZ - Azerbaigian 12
EG - Egitto 12
KZ - Kazakistan 12
MY - Malesia 12
AE - Emirati Arabi Uniti 11
DZ - Algeria 11
GP - Guadalupe 11
NP - Nepal 11
AU - Australia 10
PE - Perù 10
CH - Svizzera 9
ET - Etiopia 9
OM - Oman 9
PR - Porto Rico 9
PS - Palestinian Territory 9
RO - Romania 8
UY - Uruguay 8
EE - Estonia 7
LB - Libano 7
MU - Mauritius 7
SK - Slovacchia (Repubblica Slovacca) 7
BO - Bolivia 6
TH - Thailandia 6
AL - Albania 5
BY - Bielorussia 5
DK - Danimarca 5
GR - Grecia 5
HU - Ungheria 5
KW - Kuwait 5
PA - Panama 5
PT - Portogallo 5
BB - Barbados 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
GY - Guiana 3
IR - Iran 3
KH - Cambogia 3
LK - Sri Lanka 3
MK - Macedonia 3
MN - Mongolia 3
NZ - Nuova Zelanda 3
RS - Serbia 3
AM - Armenia 2
AO - Angola 2
BW - Botswana 2
Totale 25.536
Salva come PNG Salva come JPEG
Città #
San Jose 1.245
Dublin 954
Chandler 951
Ashburn 944
Singapore 920
Council Bluffs 799
Hong Kong 729
Dallas 700
Jacksonville 616
Nanjing 564
Beijing 510
Boardman 314
Los Angeles 273
Ho Chi Minh City 264
Nanchang 228
Lauterbourg 217
Hanoi 188
New York 188
Princeton 188
Lawrence 181
Milan 176
Wilmington 175
Munich 171
Shenyang 161
Changsha 151
Helsinki 144
Santa Clara 141
Johannesburg 138
Ann Arbor 137
Jiaxing 119
Hebei 114
Medford 111
Moscow 111
Redondo Beach 108
Tianjin 99
Buffalo 97
Shanghai 92
Turku 86
Hangzhou 85
Orem 85
Pavia 76
Rome 75
São Paulo 67
Woodbridge 67
Dearborn 62
Phoenix 62
Warsaw 56
Atlanta 55
Chicago 55
Denver 55
Tokyo 55
Montreal 53
Houston 50
Brooklyn 49
Columbus 49
Frankfurt am Main 49
Toronto 48
Verona 48
Nuremberg 46
London 45
Seattle 44
Chennai 42
Da Nang 38
San Francisco 38
Norwalk 36
The Dalles 36
North Bergen 35
Naples 34
Brussels 33
Boston 31
Turin 31
San José 28
Amsterdam 27
Haiphong 27
Mexico City 27
Rio de Janeiro 27
Falls Church 26
Guangzhou 26
Washington 26
Kunming 25
Bologna 24
Brasília 24
Falkenstein 24
Florence 24
Pune 24
Baghdad 23
Managua 23
Stockholm 22
Curitiba 20
San Salvador 20
Willemstad 20
Biên Hòa 19
Des Moines 19
Fairfield 19
Piscataway 19
Guayaquil 18
Paris 18
Poplar 18
Tashkent 18
Mumbai 17
Totale 15.646
Salva come PNG Salva come JPEG
Nome #
Time trends in smoking habits among Italian young adults 221
An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. 220
Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of invasive pulmonary aspergillosis: a prospective cohort study 202
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 200
Temporal trend in the prevalence of asthma-like symptoms among young adults of Northern Italy. Results of European Community Respiratory Health Survey (ECRHS) – ITALY 2000 180
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 174
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 173
Persistent exercise limitation after successful pulmonary endoarterectomy: frequency and determinants 171
Assessment and management of pulmonary alveolar proteinosis in a reference center. 169
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 166
Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration 163
Test di provocazione bronchiale con metacolina (TPBM). Riflessioni sulle linee guida ATS 1999 – confronti con le linee guida ERS 1993. 162
Lyosecretome for use in the treatment of degenerative osteoarticular diseases and/or degenerative intervertebral disc disease. 162
Chronic cough and phlegm in young adults 161
Asthma control in Europe: a real-world evaluation based on an international population-based study 156
Changes in IgE sensitization and total IgE levels over 20 years of follow-up 156
Lyosecretome for use in the treatment of autoimmune diseases 156
ADRB2 Gly16Arg polymorphism, asthma control and lung function decline. 153
Allergen-specific immunoglobulin E and allergic rhinitis severity 153
Lyosecretome for use in the treatment or prevention of skin aging by inhibiting elastase and tyrosinase activity 153
"Nonobstructive" emphysema of the lung 151
Antihistamines in children and adolescents: A practical update 151
Athletic protocol in non-cystic fibrosis-related bronchiectasis: rationale and design of the pilot ATHOS study 150
Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study 149
Allergic rhinitis and asthma comorbidity in a survey of young adults in Italy. 148
Bronchial responsiveness to ultrasonic fog in occupational asthma due to toluene diisocyanate 146
Are the asthma guideline goals achieved in daily practice? A population-based study on treatment adequacy and the control of asthma 146
Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies 143
Aerosol thermal therapy benefit in chronic bronchitis treatment. 142
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 142
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 142
Assessment of emphysema in COPD. A functional and radiologic study 140
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome 140
Il test da sforzo cardiopolmonare (TCP) nello studio delle malattie respiratorie e in riabilitazione. Parte II. 139
Exacerbations as a starting point of pro-active chronic obstructive pulmonary disease management. 138
Mechanisms for isolated volume response to a bronchodilator in patients with COPD 138
Chronic productive cough in young adults is very often due to chronic rhino-sinusitis 137
Lyosecretome for use in the treatment of alpha-1-antitrypsin deficiency associated diseases 137
Lung bronchiectasisas a paradigm of the interplay between infection and colonization on plastic modulation of the pre-metastatic niche 136
The relationship between allergen immunotherapy and omalizumab for treating asthma 135
Mesenchymal Extracellular Vesicles as Alpha-1-antitrypsin physiological delivery systems for lung regeneration 135
Long-term effects of pulmonary andoarterectomy on cardioplmonary function and exercise tolerance 134
Longterm hemodynamic and functional results after pulmonary endarterectomy 128
COVID vaccination and asthma exacerbation: might there be a link? 127
Freeze-dried MSC-secretome contains active alpha-1-antitrypsin for treatment of deficiency pulmonary diseases 126
Long-term outcome after pulmonary endarterectomy. 125
Pulmonary involvement in patients with Marfan Syndrome. 124
Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital 124
Changes in the use of anti-asthmatic medication in an international cohort. 123
A three-generation study on the association of tobacco smoking with asthma 123
Asthmatics and ex-smokers respond early, heavy smokers respond late to mailed surveys in Italy. 122
Asthma-like symptoms: Is it always a pulmonary issue? 122
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD 122
Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of Invasive Pulmonary Aspergillosis: a prospective cohort study 120
Pulmonary endarterectomy: the lancet first, tears for pills. 120
International variations in asthma treatment compliance: the results of the European Community Respiratory Health Survey (ECRHS). 119
Human health and air conditioning systems. 118
Absolute values of lung function explain the sex difference in breathlessness in the general population 118
Effects of inhaled steroids on methacholine-induced bronchoconstriction and gas trapping in mild asthma. 117
Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD 117
Allergen-specific immunoglobulin E and allergic rhinitis severity 117
Lung cancer resection: the prediction of postsurgical outcomes should include long-term functional results. 116
Lung function in survivors of childhood acute lymphoblastic leukemia 116
Prevalence of allergic rhinitis in young adults in Italy 116
Il rapporto VEMS/CVF come cut-off fisso é un parametro accurato e affidabile per la diagnosi funzionale di ostruzione bronchiale nella BPCO: CON | [FEV1/FVC as a fixed cut-off is an accurate and reliable parameter for functional diagnosis of bronchial obstruction in COPD: CON] 116
Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. 116
Pharmacological treatment of asthma in a cohort of adults during a 20-year period: results from the European Community Respiratory Health Survey I, II and III 116
Clinical features in patients with severe Alpha-1 antitrypsin deficiency due to rare genotypes 115
Asthma in childhood reduces smoking initiation in subsequent teenage among males. 115
The course of asthma during pregnancy in a recent, multicase-control study on respiratory health 114
Eosinophilic cationic protein (ECP) in the clinical work-up of chronic cough 113
Comparison among populations with severe and intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease 113
The role of climate on the geographic variability of asthma, allergic rhinitis and respiratory symptoms: results from the Italian study of asthma in young adults. 112
The socio-economic burden of asthma is substantial in Europe. 112
Eosinophilic cationic protein (ECP) in the clinical work-up of chronic cough 110
Mid term effects of pulmonary thromboendarterectomy on clinical and cardiopulmonary function status 110
Il test da sforzo cardiopolmonare (TCP) nello studio delle malattie respiratorie e in riabilitazione. Parte I. 110
Linee guida per la misurazione ed interpretazione dei valori di ossigenazione arteriosa. 110
Patients' interest in educational programmes on asthma. 110
Malignant Pleural Mesothelioma: From Pathophysiology to Innovative Actionable Targets 109
Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults 109
Quality-of-life and asthma-severity in general population asthmatics: results of the ECRHS II study 109
Late pulmonary sequelae after childhood bone marrow transplantation 109
Freeze-dried MSC-secretome for use in the treatment of alpha-1-antitrypsin deficiency pulmonary diseases 109
Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach 108
Incidence of COPD in a Cohort of Young Adults According to the Presence of Chronic Cough and Phlegm. 108
Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and covid-19: A multicenter case-control retrospective observational study 107
Bioequivalence of inhaled formoterol fumarate assessed from pharmacodynamic, safety and urinary pharmacokinetic data. 106
A 28-Year-Old Man with Stridor and Dyspnea 106
Assessment of asthma severity in adults with ever asthma: A continuous score 105
SORVEGLIANZA DELLE MALATTIE BRONCOPOLMONARI CRONICO-OSTRUTTIVE NELLA POPOLAZIONE DI ROVESCALA (PAVIA) IN RELAZIONE ALL’ ESPOSIZIONE AL FUMO DI TABACCO 105
Effects of exercise and beta 2-agonists on lung function in chronic obstructive pulmonary disease 104
Occupational asthma caused by milk proteins: report on a case. 103
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 103
Radiographic findings in 240 patients with COVID-19 pneumonia: time-dependence after the onset of symptoms 103
Asthma Severity According to Global Initiative for Asthma and Its Determinants:An International Study. 102
Inadequate antiasthma drug use in the north of Italy. 101
MSC extracellular vesicles for treatment of alpha-1-antitrypsin deficiency pulmonary diseases 101
Atmosphere pollutants 100
Peak expiratory flow monitoring and airway response to specific bronchial provocation tests in asthmatics 100
Totale 13.129
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.359
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022737 0 0 0 0 26 33 34 41 55 23 137 388
2022/20232.791 341 144 27 278 230 284 7 180 1.151 21 82 46
2023/20241.079 118 203 47 65 118 238 51 85 10 48 30 66
2024/20253.719 70 223 102 149 94 322 186 238 867 194 397 877
2025/20269.599 654 690 993 1.196 1.070 401 1.837 448 913 654 427 316
2026/20273.493 388 551 670 1.303 581 0 0 0 0 0 0 0
Totale 25.857